×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Anti Ageing Drugs Market

ID: MRFR/Pharma/2408-CR
260 Pages
Rahul Gotadki
February 2021

按药物类别(血清和补充剂、抗氧化剂和酶、干细胞和药物)、按地区(北美、欧洲、亚太地区和世界其他地区)划分的应用(皮肤和头发、骨骼和肌肉、年龄相关疾病等)的抗衰老药物市场研究报告信息 - 预测至 2032 年

分享
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Anti Ageing Drugs Market Infographic
Purchase Options

全球抗衰老药物市场概览

p2023 年抗衰老药物市场规模价值 449 亿美元,预计将从 2024 年的 479.9 亿美元增长到 2032 年的 833.9 亿美元,预测期内(2024 - 2032 年)的复合年增长率 (CAGR) 为 6.9%。老龄人口的增加、可支配收入的高水平、生活方式产业的影响和人们意识的不断提高,都在推动着市场的增长。

抗衰老药物市场概览

来源:二手资料研究、一手资料研究、MRFR 数据库和分析师评论

抗衰老药物市场趋势

ul
  • 老龄人口的增加推动市场增长
p全球老年人口的强劲快速增长为抗衰老药物的开发创造了广泛的可能性。不断增长的老龄人口成为抗衰老药物的目标市场,推动着市场向前发展。根据世界卫生组织 (WHO) 的数据,到 2050 年,60 岁以上人口占总人口的比例预计将翻一番,从 2015 年的 12% 达到 22%。此外,随着生活方式和时尚行业的影响力不断扩大,老年人保持年轻健康的愿望也日益强烈。此外,随着审美标准的不断提高,各个年龄段的人对抗衰老药物的兴趣也越来越浓厚。因此,抗衰老产品在老龄化人群中越来越受欢迎,这种意识的增强将推动抗衰老药物市场在未来几年大幅增长。

抗衰老药物市场细分洞察

h3抗衰老药物类别洞察 p抗衰老药物市场细分基于药物类别,包括精华液和补充剂、抗氧化剂和酶、干细胞和药物。精华液和补充剂细分市场在 2022 年的抗衰老药物市场收入中占据了大部分份额。这是由于消费者对与年龄相关的皮肤问题(例如细纹、皱纹和皮肤暗沉)的认识不断提高,并且更倾向于购买有助于展现皮肤年轻的产品。此外,大多数护肤品和化妆品,包括许多其他护肤品和化妆品,都在改变其设计。预计未来几年,抗衰老精华液市场将紧随其后。

2019年11月 em: em雅诗兰黛公司(美国)收购了Have Be Co. Ltd.(韩国)。此次收购有助于进一步巩固雅诗兰黛公司在护肤领域的领导地位,尤其有助于扩大公司在亚太地区、北美、英国和旅游零售市场的消费者覆盖范围。

图2:2023年和2024年按药物类别划分的抗衰老药物市场2032 年(十亿美元)

抗衰老药物市场,按药物类别,2022 年和 2030 年

来源:二手资料研究、一手资料研究、MRFR 数据库和分析师评论

抗衰老药物应用洞察

p抗衰老药物市场根据应用细分,包括皮肤和头发、骨骼和肌肉、与年龄相关的疾病等。2022 年,皮肤和头发领域在抗衰老药物市场收入中占据了大部分份额。这是因为人们对养生法和日常习惯的有效性越来越感兴趣,对促进健康和自我护理产品的需求也随之增加。此外,2021 年,护肤品占据首位,约占全球市场的 41%。另外 22% 用于护发产品,约 16% 用于化妆品。护肤品是最赚钱的产品类别之一,预计 2026 年销售额将达到 1880 亿美元。截至 2021 年,北亚地区占该行业约 35% 的份额。

2021 年 6 月: 宝洁Gamble(美国)推出了 Nervive,这是一款全新的膳食补充剂系列,其研发团队凝聚了 Gamble 50 多年的神经护理专业知识,旨在促进美国的神经健康。

抗衰老药物区域洞察

p按地区划分,该研究将市场细分为北美、欧洲、亚太地区和世界其他地区。北美抗衰老药物市场占据最大市场份额。这归因于该地区可支配收入高、人们对审美外貌的认识不断提高以及对衰老迹象的认识不断提高。根据美国人口普查局的数据,联合国约有 8310 万千禧一代,占全国人口的四分之一以上。因此,这些因素共同导致了该地区抗衰老药物市场的扩张。

此外,研究的主要国家是美国、加拿大、德国、法国、英国、意大利、西班牙、中国、日本、印度、澳大利亚、韩国和巴西。

图 3:2023 年和 2024 年各地区抗衰老药物市场份额2032 年(十亿美元)

2022 年和 2030 年各地区抗衰老药物市场份额

来源:二手资料研究、一手资料研究、MRFR 数据库和分析师评论

由于欧洲地区老龄化人口庞大,预计欧洲抗衰老药物市场将占据第二大市场份额。此外,预计德国抗衰老药物市场将占据市场份额的第三位,英国抗衰老药物市场预计将成为增长最快的市场,在欧洲地区排名第四。此外,法国抗衰老药物市场将占据市场份额的第五位。

预计亚太抗衰老药物市场将在 2024 年至 2032 年间保持稳步增长。这是由于该地区生活方式的改变。此外,预计中国抗衰老药物市场将占据最大的市场份额,而印度抗衰老药物市场预计将是亚太地区增长最快的市场。

此外,中国在生产和消费方面继续位居支持护肤品和化妆品行业增长的前列,包括抗衰老、防晒和美白产品。全国范围内老年人口的增长将增加对抗衰老药物的需求,预计这将推动抗衰老药物市场的增长。

世界其他地区包括中东、非洲和拉丁美洲。预计这一部分在抗衰老药物市场中所占份额最小。此外,由于赤贫、腐败、经济增长缓慢、政治条件不稳定,预计中东北非 (MENA) 和世界其他地区的增长有限。

抗衰老药物主要市场参与者和竞争见解

抗衰老药物市场的特点是存在许多全球、区域和本地供应商,以满足研究科学家以及在该行业运营的制药和生物技术公司所创造的需求。市场包括一级、二级和本地参与者。一级和二级参与者遍布全球,产品组合多种多样。诸如 Merz Pharma(德国)、宝洁等公司Gamble(美国)、Nu Skin(美国)和BIOTIME Inc(美国)凭借产品差异化、财务稳定性、战略发展和多元化的区域布局,在抗衰老药物市场占据主导地位。这些参与者专注于投资研发。此外,他们采取扩张、产品发布、合资企业和合作伙伴关系等战略增长举措,以巩固其市场地位并吸引庞大的客户群。

抗衰老药物行业制造商为使客户受益并扩大抗衰老药物市场而采用的主要商业策略之一是在当地生产以降低运营成本。

宝洁公司(Procter Gamble)在全球范围内生产、营销、分销和销售消费包装商品。该公司通过五个业务部门运营,即美容、美容、医疗保健、织物和家庭护理以及婴儿、女性和家庭护理。其美容部门下的护发类别包括洗发水、护发素和美发产品。该公司通过大众零售商、药店、百货公司、美容专卖店、高频商店和药房等渠道销售产品。例如,2020年6月,美国Elysium Health Inc.推出了SIGNALTM,它以独特的方式结合了最强效的SIRT3激活剂和最直接的NAD+前体NMN,旨在补充因衰老而流失的必需代谢因子,从而支持健康的线粒体功能并促进健康的新陈代谢。

此外,德国Merz Pharma是一家拥有强大研发能力的美容和神经毒素公司。其美容产品以其卓越的品质和卓越的效果而闻名。该公司致力于满足和发现专家的需求,并与专家们携手合作,帮助患者达到预期效果。其护肤产品组合涵盖疤痕、痤疮、脱发和真菌病等治疗。该公司的业务范围还涵盖神经病学、非处方药 (OTC) 和膳食补充剂等领域。其业务遍及 34 多个国家/地区,并在约 90 个国家/地区销售其产品。

抗衰老药物市场的主要公司包括

    • 宝洁Gamble(美国)
    • Nu Skin(美国)
    • BIOTIME Inc(美国)
    • Elysium Health Inc (美国)
    • La Roche-Posay (英国)
    • DermaFix (南非)
    • 欧莱雅(法国)
    • 雅诗兰黛公司(美国)
    • 欧瑞莲化妆品(瑞士)
p抗衰老药物行业发展

2022年9月:

2020 年 2 月:

2022 年 5 月:理肤泉 (La Roche-Posay)(英国)推出了新款抗衰老面部防晒霜 SPF 70 日常抗衰老面部防晒霜,经过所有皮肤类型的临床测试。 Anthelios UV Correct SPF 70 日常抗衰老面部防晒霜采用 Cellox-B3 Shield 技术配制而成,可矫正和保护皮肤免受阳光伤害的迹象。

2023 年 1 月:

抗衰老药物市场细分

抗衰老药物类别展望

    • 精华液和补充剂
    • 抗氧化剂和酶
    • 干细胞
    • 药物

抗衰老药物应用展望

    • 皮肤和头发
    • 骨骼和肌肉
    • 年龄相关疾病
    • 其他

抗衰老药物区域展望

    • 北美
      • 美国
      • 加拿大
    • 欧洲
      • 德国
      • 法国
      • 英国
      • 意大利
      • 西班牙
      • 其他地区欧洲
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 亚太地区其他地区
    • 世界其他地区
      • 中东
      • 非洲
      • 拉丁美洲

市场亮点

作者
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

发表评论

FAQs

What is the current valuation of the Anti-Ageing Drugs Market?

The Anti-Ageing Drugs Market was valued at 47.9 USD Billion in 2024.

What is the projected market size for the Anti-Ageing Drugs Market by 2035?

The market is projected to reach 100.0 USD Billion by 2035.

What is the expected CAGR for the Anti-Ageing Drugs Market during the forecast period?

The expected CAGR for the Anti-Ageing Drugs Market from 2025 to 2035 is 6.92%.

Which companies are considered key players in the Anti-Ageing Drugs Market?

Key players include Allergan, Galderma, Revance Therapeutics, Medytox, Hugel, Ipsen, and Sientra.

What are the main segments of the Anti-Ageing Drugs Market?

The main segments include Drug Class and Application, with various subcategories.

How much revenue is generated from Serums and Supplements in the market?

Revenue from Serums and Supplements is projected to range from 15.0 to 30.0 USD Billion.

What is the revenue range for Antioxidants and Enzymes in the market?

Antioxidants and Enzymes are expected to generate revenue between 10.0 and 20.0 USD Billion.

Research Approach

Research Methodology on Anti Ageing Drugs Market

Research Approach

The research approach for this research report is divided into five distinct sections, namely: 1) Literature review, 2) Development and Evaluation of the Research Model,3) Data Collection and Analysis, 4) Results and Findings and 5) Conclusion.

1. Literature review

For this research, a literature review is done to gain a holistic understanding of the Anti-ageing Drugs market. The extent of the literature reviewed is mainly focused on current market trends, emerging technologies, drivers and restraints, market segments, competitive landscape, etc. Primary sources include published reports, books and other documents and secondary sources include government reports, analyst reports newspaper and magazine articles, databases, online materials and internet resources. The findings of the literature review were used to gain an insight into the competitive dynamics of the Anti-ageing Drugs market, key opportunities and sales outlook.

2. Development and Evaluation of the Research Model

The research model for this research report is developed using PESTEL and Porter’s Five Force Analysis framework. Through PESTEL analysis, the key macro-environmental factors that affect the Anti-ageing Drugs market were identified and analysed. Alongside, Porter’s Five Forces analysis was used to determine the competitive intensity within the market, further allowing the research team to gain insight into the bargaining powers of suppliers, buyers, and the extent of competition within the market.

3. Data Collection and Analysis

The data used in this research report is collected from a variety of sources including primary and secondary sources. Primary sources include interviews with industry experts and industry stakeholders. The interviews were conducted to gain an in-depth understanding of the market dynamics, current trends, challenges, etc. Secondary sources include industry journals, newspapers, and other published documents available in the public domain. The research team also conducted an in-depth analysis of the published reports, databases such as Bloomberg, Factiva, and EDGAR.

The data collected from these different sources were analysed using both qualitative and quantitative research techniques. Statistical tools such as SPSS and EXCEL were used for analysing the data to identify trends and relationships.

4. Results and Findings

The results and findings of the research report were based on the analysis carried out on the collected data. Based on the analysis, the report provided a detailed overview of the Anti-ageing Drugs market, with an in-depth analysis of the market drivers, challenges, and opportunities. It also provided an analysis of the various market segments and a detailed view of the competitive landscape.

5. Conclusion

Based on the results and findings, the research report provided a detailed overview of the Anti-ageing Drugs market and a detailed analysis of the key market players. Further, it provided an insight into the challenges and opportunities in the Anti-ageing Drugs market. The research report concluded with a comprehensive evaluation of the market trends, segment outlook, and an outlook for the future of the Anti-ageing Drugs market.

下载免费样本

请填写以下表格以获取本报告的免费样本

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions